Smallpox vaccination: A review, part I. Background, vaccination technique, normal vaccination and revaccination, and expected normal reactions

Clinical Infectious Diseases

Volumn 37, Issue 2, 2003, Pages 241-250

  Fulginiti, Vincent A ^a,b,i   Papier, Arthur ^c   Lane, J Michael ^d,h   Neff, John M ^e,f   Henderson, D A ^g  

^a UNIVERSITY OF ARIZONA COLLEGE OF MEDICINE   (United States)

^b Children's Hospital Colorado   (United States)

^c UNIVERSITY OF ROCHESTER   (United States)

^d EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

^e SEATTLE CHILDREN S RESEARCH INSTITUTE   (United States)

^f UNIVERSITY OF WASHINGTON   (United States)

^g JOHNS HOPKINS UNIVERSITY   (United States)

^h CENTERS FOR DISEASE CONTROL AND PREVENTION   (United States)

ⁱ NONE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

SMALLPOX VACCINE;

BIOLOGICAL WARFARE; CHILL; DISEASE ASSOCIATION; DISEASE CONTROL; EDEMA; ERYTHEMA; FATIGUE; FEVER; HEADACHE; HEALTH CARE PERSONNEL; HEALTH PROMOTION; HUMAN; IMMUNIZATION; INFLAMMATION; LYMPHADENOPATHY; LYMPHANGITIS; MALAISE; MYALGIA; NAUSEA; PAIN; PAPULE; PRACTICE GUIDELINE; PRIORITY JOURNAL; PROPHYLAXIS; PUSTULE; REVIEW; SKIN MANIFESTATION; SMALLPOX; SMALLPOX VIRUS; SOLDIER; UNITED STATES; VACCINATION; WORLD HEALTH ORGANIZATION; DRUG CONTRAINDICATION; IMMUNOLOGY; LEGAL ASPECT; METHODOLOGY; PREVENTIVE HEALTH SERVICE; PUBLIC HEALTH SERVICE;

BIOTERRORISM; CENTERS FOR DISEASE CONTROL AND PREVENTION (U.S.); HEALTH PERSONNEL; HUMANS; IMMUNIZATION PROGRAMS; MILITARY PERSONNEL; SMALLPOX; SMALLPOX VACCINE; UNITED STATES; VACCINATION;

EID: 0042532341     PISSN: 10584838     EISSN: None     Source Type: Journal    
DOI: 10.1086/375824     Document Type: Review

References (28)

1. Fenner F. Global eradication of smallpox. Rev Infect Dis 1982; 4:916-30.
2. Shooter RA. Report of the investigation into the cause of the 1978 Birmingham smallpox occurrence. London: Her Majesty's Stationery Office, 1980.
3. Hawkes N. Smallpox death in Britain challenges presumption of laboratory safety: peer review failed dismally. Science 1979; 203:855-6.
4. Fulginiti VA, Papier A, Lane JM, Neff JM, Henderson DA. Smallpox vaccination: a review, part II. Adverse events. Clin Infect Dis 2003; 37:251-71 (in this issue).
5. Fenner F, Henderson D, Jezek AZ, Ladnyi ID. Smallpox and its eradication. Geneva: World Health Organization, 1988.
6. Gellman B. Four nations thought to possess smallpox. The Washington Post. 5 November 2002:A1, cols 4-5.
7. Dixon CW. Smallpox. London: J&A Churchill, 1962.
8. Jenner E. An inquiry into the causes and effects of the variolae vaccinae. London: Low, 1798.
9. de Vries RRP, Kreeftenberg HG, Loggen HG, van Rood JJ. In vitro immune responsiveness to vaccinia virus and HLA. N Engl J Med 1977; 297:692-6.
10. Moller-Larsen A, Haahr S. Humoral and cell-mediated immune responses in humans before and after revaccination with vaccinia virus. Infect Immun 1978; 19:34-9.
11. McLaren C, Cheng H, Spicer DL, Tompkins WAF. Lymphocyte and macrophage responses after vaccinia virus infections. Infect Immun 1976; 14:1014-21.
12. + cytotoxic T lymphocytes and interferon-γ-producing T cells after smallpox vaccination. J Infect Dis 2002; 185:1657-9.
13. Fulginiti VA, Kempe CH, Hathaway WE, et al. Progressive vaccinia in immunologically deficient individuals. In: Good R, ed. Immunologic diseases of man. Birth Defects Original Article Series, vol 4. New York: The National Foundation March of Dimes, 1968:129-51.
14. El-Ad B, Roth Y, Winder A, et al. The persistence of neutralizing antibodies after revaccination against smallpox. J Infect Dis 1990; 161:446-8.
15. Demkowicz WE, Littawa RA, Want J, Ennis FA. Human cytotoxic T-cell memory: long-lived response to vaccinia virus. J Virol 1996; 70:2627-31.
16. Frelinger JA, Garba ML. Responses to smallpox vaccine [letter]. N Engl J Med 2002; 347:689-90.
17. Mack TM, Thomas DB, Ali A, Khan M. Epidemiology of smallpox in West Pakistan. 1. Acquired immunity and the distribution of disease. Am J Epidemiol 1972; 95:157-68.
18. Mack TM. Smallpox in Europe, 1950-1971. J Infect Dis 1972; 125:161-9.
19. Centers for Disease Control and Prevention. Vaccinia (smallpox) vaccine: recommendations of the Advisory Committee on Immunization Practices (ACIP), 2001. MMWR Recomm Rep 2001; 50(RR-10):1-25. Available at: http://www.cdc.gov/mmwr/preview/mmwrhtml/rr5010a1.htm.
20. Frey SE, Couch RB, Tacket CO, et al. Clinical responses to undiluted and diluted smallpox vaccine. N Engl J Med 2002; 346:1265-74.
21. Frey SE, Newman FK, Cruz J, et al. Dose related effects of smallpox vaccine. N Engl J Med 2002; 346:1275-80.
22. Richwine L. Acambis, Baxter win smallpox contract. Reuters News Service. 28 November 2001. Available at: http://www.ph.ucla.edu/epi/bioter/smallpoxcontract.html.
23. Centers for Disease Control and Prevention. Smallpox vaccination and adverse events training module. Available at: http://www.bt.cdc.gov/training/smallpoxvaccine/reactions. Accessed December 2002.
24. Neff JM, Lane JM, Fulginiti VA, Henderson DA. Contact vaccinia. JAMA 2002; 288:1901-5.
25. Redfield R, Wright D, James W, Jones T, Brown C, Burke D. Disseminated vaccinia in a military recruit with human deficiency virus (HIV) disease. N Engl J Med 1987; 316:673-6.
26. Bartlett JG. Smallpox vaccination and patients with human immunodeficiency virus infection or acquired immunodeficiency syndrome. Clin Infect Dis 2003; 36:468-71.
27. Centers for Disease Control and Prevention. Temporary deferral recommended for heart patients volunteering for smallpox vaccination [press release]. 25 March 2003. Available at: http://www.cdc.gov/od/oc/media/pressrel/r030325.htm.
28. World Health Organization (WHO). WHO fact sheet on smallpox: vaccines. October 2001. Available at: http://www.who.int/emc/diseases/smallpox/factsheet.html#Vaccines.